<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163220">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02031796</url>
  </required_header>
  <id_info>
    <org_study_id>13-004257</org_study_id>
    <nct_id>NCT02031796</nct_id>
  </id_info>
  <brief_title>Cardiac Vascular Reconstruction DynaCT for TAVI Procedures</brief_title>
  <acronym>CAVAREC</acronym>
  <official_title>Cardiac Vascular Reconstruction (CAVAREC) DynaCT for 3D Assessment of Aortic Valve During TAVI Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Siemens Medical Solutions USA - CSG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this work is to evaluate the feasibility of a new Cardiac Vascular
      Reconstruction (CAVAREC, Siemens Medical Systems, Germany) image reconstruction algorithm
      for use during transcatheter aortic valve implant (TAVI) procedures.   CAVAREC utilizes the
      same x-ray projection images as currently acquired for clinical DynaCT.  X-ray image
      acquisition to allow CAVAREC will occur during the TAVI procedure both before and after the
      TAVI device is implanted.  The CAVAREC image processing algorithm will be implemented on an
      off-line workstation after the TAVI procedure is complete.  After the TAVI procedure,
      CAVAREC images will be quantitatively and qualitatively compared to Siemens DynaCT and
      cardiac CT images from Radiology.  The results of this study will be used to direct further
      development of CAVAREC toward the end goal of providing improved imaging capabilities to
      guide TAVI procedures.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Number of images of the aortic valve that are accurate</measure>
    <time_frame>approx 2 hours after surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>Qualitative image assessment will be performed by Board Certified Cardiologists and/or Radiologists who are familiar with cardiac CT image manipulation and interpretation.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Aortic Valve Disease</condition>
  <arm_group>
    <arm_group_label>CAVAREC images</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CAVAREC images from x-ray angiography</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CAVAREC Image Processing algorithm</intervention_name>
    <arm_group_label>CAVAREC images</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient scheduled for surgical repair of aortic valve

        Exclusion Criteria:

          -  Patient enrolled Partner II or other research protocol related to TAVI.

          -  Creatinine &gt; 3.0 mg/dl

          -  Lack of research consent.

          -  Lack of pre-procedure contrast enhanced Radiology cardiac CT
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Verghese Mathew, M.D.</last_name>
    <phone>507-538-1469</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pamela R. Vega, B.S.</last_name>
    <phone>507-255-6884</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Verghese Mathew, M.D.</last_name>
      <phone>507-538-1469</phone>
    </contact>
    <contact_backup>
      <last_name>Pamela R. Vega, B.S.</last_name>
      <phone>507-255-6884</phone>
    </contact_backup>
    <investigator>
      <last_name>Verghese Mathew, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 7, 2014</lastchanged_date>
  <firstreceived_date>January 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Verghese Mathew, M.D.</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
